Stock listing
KRX:205470 HUMASIS Co., Ltd. (휴마시스) 주가
Follow HUMASIS Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:205470
₩2,230.00 KRW +30.00 (+1.4%)
Close on Nov 20, 2026
- Day range
- ₩2,150.00 – ₩2,250.00 KRWNov 20, 2026
- Volume
- 68,451 sharesNov 20, 2026
- Market cap
- ₩50.44B KRWAt the close on Nov 20, 2026 · price × 22.62M shares outstanding
- 52-week range
- ₩1,898.00 – ₩6,210.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩445.2M KRWMedian day 49,603 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:205470 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,230.00 | +30.00 | +1.4% | ₩2,150.00 | ₩2,250.00 | ₩2,150.00 | 68,451 | |
| ₩2,200.00 | +35.00 | +1.6% | ₩2,155.00 | ₩2,265.00 | ₩2,155.00 | 46,050 | |
| ₩2,165.00 | -60.00 | -2.7% | ₩2,225.00 | ₩2,495.00 | ₩2,070.00 | 60,826 | |
| ₩2,225.00 | -295.00 | -11.7% | ₩2,540.00 | ₩2,710.00 | ₩2,225.00 | 212,647 | |
| ₩2,520.00 | +205.00 | +8.9% | ₩2,290.00 | ₩2,995.00 | ₩2,285.00 | 762,393 | |
| ₩2,315.00 | +40.00 | +1.8% | ₩2,260.00 | ₩2,325.00 | ₩2,255.00 | 45,584 | |
| ₩2,275.00 | +75.00 | +3.4% | ₩2,195.00 | ₩2,285.00 | ₩2,195.00 | 11,789 | |
| ₩2,200.00 | -35.00 | -1.6% | ₩2,235.00 | ₩2,300.00 | ₩2,165.00 | 32,937 | |
| ₩2,235.00 | +60.00 | +2.8% | ₩2,150.00 | ₩2,240.00 | ₩2,150.00 | 15,163 | |
| ₩2,175.00 | -40.00 | -1.8% | ₩2,190.00 | ₩2,200.00 | ₩2,100.00 | 49,314 | |
| ₩2,215.00 | -25.00 | -1.1% | ₩2,200.00 | ₩2,270.00 | ₩2,200.00 | 38,973 | |
| ₩2,240.00 | -15.00 | -0.7% | ₩2,255.00 | ₩2,255.00 | ₩2,150.00 | 39,953 | |
| ₩2,255.00 | -65.00 | -2.8% | ₩2,315.00 | ₩2,315.00 | ₩2,190.00 | 37,444 | |
| ₩2,320.00 | -10.00 | -0.4% | ₩2,295.00 | ₩2,385.00 | ₩2,275.00 | 22,165 | |
| ₩2,330.00 | -55.00 | -2.3% | ₩2,435.00 | ₩2,440.00 | ₩2,280.00 | 87,008 | |
| ₩2,385.00 | -80.00 | -3.2% | ₩2,465.00 | ₩2,500.00 | ₩2,320.00 | 64,456 | |
| ₩2,465.00 | +85.00 | +3.6% | ₩2,390.00 | ₩2,475.00 | ₩2,330.00 | 32,943 | |
| ₩2,380.00 | +15.00 | +0.6% | ₩2,365.00 | ₩2,445.00 | ₩2,360.00 | 35,178 | |
| ₩2,365.00 | -115.00 | -4.6% | ₩2,595.00 | ₩2,595.00 | ₩2,340.00 | 42,366 | |
| ₩2,480.00 | -35.00 | -1.4% | ₩2,515.00 | ₩2,515.00 | ₩2,400.00 | 33,559 | |
| ₩2,515.00 | -70.00 | -2.7% | ₩2,510.00 | ₩2,620.00 | ₩2,400.00 | 45,487 | |
| ₩2,585.00 | -20.00 | -0.8% | ₩2,640.00 | ₩2,720.00 | ₩2,570.00 | 33,180 | |
| ₩2,605.00 | -70.00 | -2.6% | ₩2,680.00 | ₩2,750.00 | ₩2,605.00 | 20,386 | |
| ₩2,675.00 | +5.00 | +0.2% | ₩2,670.00 | ₩2,690.00 | ₩2,550.00 | 38,386 | |
| ₩2,670.00 | +155.00 | +6.2% | ₩2,485.00 | ₩2,695.00 | ₩2,485.00 | 49,892 | |
| ₩2,515.00 | -145.00 | -5.5% | ₩2,605.00 | ₩2,715.00 | ₩2,505.00 | 103,414 | |
| ₩2,660.00 | 0.00 | 0.0% | ₩2,665.00 | ₩2,920.00 | ₩2,625.00 | 153,876 | |
| ₩2,660.00 | -175.00 | -6.2% | ₩2,810.00 | ₩2,815.00 | ₩2,640.00 | 173,734 | |
| ₩2,835.00 | -25.00 | -0.9% | ₩2,860.00 | ₩3,070.00 | ₩2,835.00 | 312,018 | |
| ₩2,860.00 | -260.00 | -8.3% | ₩3,060.00 | ₩3,060.00 | ₩2,755.00 | 506,955 | |
| ₩3,120.00 | +515.00 | +19.8% | ₩2,660.00 | ₩3,385.00 | ₩2,660.00 | 2,687,355 | |
| ₩2,605.00 | -15.00 | -0.6% | ₩2,690.00 | ₩2,690.00 | ₩2,580.00 | 28,301 | |
| ₩2,620.00 | +15.00 | +0.6% | ₩2,620.00 | ₩2,710.00 | ₩2,585.00 | 36,451 | |
| ₩2,605.00 | +105.00 | +4.2% | ₩2,460.00 | ₩2,650.00 | ₩2,460.00 | 68,522 | |
| ₩2,500.00 | -60.00 | -2.3% | ₩2,600.00 | ₩2,600.00 | ₩2,500.00 | 29,385 | |
| ₩2,560.00 | -45.00 | -1.7% | ₩2,605.00 | ₩2,620.00 | ₩2,550.00 | 21,374 | |
| ₩2,605.00 | +5.00 | +0.2% | ₩2,555.00 | ₩2,665.00 | ₩2,550.00 | 38,191 | |
| ₩2,600.00 | -20.00 | -0.8% | ₩2,620.00 | ₩2,680.00 | ₩2,550.00 | 37,779 | |
| ₩2,620.00 | -35.00 | -1.3% | ₩2,660.00 | ₩2,700.00 | ₩2,580.00 | 45,558 | |
| ₩2,655.00 | -60.00 | -2.2% | ₩2,775.00 | ₩2,775.00 | ₩2,610.00 | 42,604 | |
| ₩2,715.00 | -120.00 | -4.2% | ₩2,850.00 | ₩2,860.00 | ₩2,680.00 | 70,522 | |
| ₩2,835.00 | -105.00 | -3.6% | ₩2,880.00 | ₩2,940.00 | ₩2,805.00 | 28,594 | |
| ₩2,940.00 | +80.00 | +2.8% | ₩2,940.00 | ₩2,980.00 | ₩2,800.00 | 40,951 | |
| ₩2,860.00 | -60.00 | -2.1% | ₩2,915.00 | ₩3,025.00 | ₩2,860.00 | 32,388 | |
| ₩2,920.00 | +85.00 | +3.0% | ₩2,800.00 | ₩2,935.00 | ₩2,790.00 | 50,460 | |
| ₩2,835.00 | -25.00 | -0.9% | ₩2,910.00 | ₩2,930.00 | ₩2,835.00 | 28,745 | |
| ₩2,860.00 | -140.00 | -4.7% | ₩3,000.00 | ₩3,000.00 | ₩2,845.00 | 96,509 | |
| ₩3,000.00 | -105.00 | -3.4% | ₩3,100.00 | ₩3,100.00 | ₩2,995.00 | 28,580 | |
| ₩3,105.00 | -130.00 | -4.0% | ₩3,235.00 | ₩3,285.00 | ₩3,050.00 | 70,211 | |
| ₩3,235.00 | -75.00 | -2.3% | ₩3,330.00 | ₩3,450.00 | ₩3,140.00 | 73,582 | |
| ₩3,310.00 | +95.00 | +3.0% | ₩3,300.00 | ₩3,345.00 | ₩3,160.00 | 68,234 | |
| ₩3,215.00 | +115.00 | +3.7% | ₩3,135.00 | ₩3,310.00 | ₩3,060.00 | 108,851 | |
| ₩3,100.00 | 0.00 | 0.0% | ₩3,100.00 | ₩3,170.00 | ₩3,005.00 | 59,414 | |
| ₩3,100.00 | +110.00 | +3.7% | ₩2,960.00 | ₩3,100.00 | ₩2,955.00 | 76,188 | |
| ₩2,990.00 | -115.00 | -3.7% | ₩3,105.00 | ₩3,150.00 | ₩2,950.00 | 117,752 | |
| ₩3,105.00 | +165.00 | +5.6% | ₩3,040.00 | ₩3,185.00 | ₩2,960.00 | 249,690 | |
| ₩2,940.00 | -35.00 | -1.2% | ₩2,910.00 | ₩3,120.00 | ₩2,910.00 | 120,946 | |
| ₩2,975.00 | +75.00 | +2.6% | ₩2,905.00 | ₩2,985.00 | ₩2,840.00 | 95,706 | |
| ₩2,900.00 | -180.00 | -5.8% | ₩3,025.00 | ₩3,025.00 | ₩2,790.00 | 202,247 | |
| ₩3,080.00 | +175.00 | +6.0% | ₩3,195.00 | ₩3,650.00 | ₩3,065.00 | 1,591,264 | |
| ₩2,905.00 | +30.00 | +1.0% | ₩2,900.00 | ₩2,945.00 | ₩2,765.00 | 57,969 | |
| ₩2,875.00 | +85.00 | +3.0% | ₩2,770.00 | ₩2,955.00 | ₩2,760.00 | 91,342 |
Splits
2 splits since 2023 · KRX:205470 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-5 | Consolidation | |
| 4-for-1 | Split |
- Ticker
- KRX:205470
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
HUMASIS Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales −3.8× against a median of 1.0×: the lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- −₩120.0B KRW
- P/E
- Loss
- EV/sales
- −3.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.2×
- Gross margin
- 10.7%
- Operating margin
- −44.8%
- Net margin
- −49.2%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| HUMASIS Co., Ltd. · KRX:205470 | US$37.49M | −US$89.15M | n/a | −3.8× | n/a | 0.2× | −49.2% | 0.0× | n/a |
| Osang Healthcare Co. Ltd. · KRX:036220 | US$42.35M | US$24.18M | n/a | 0.3× | n/a | 0.2× | −8.8% | 0.1× | n/a |
| ABL Diagnostics SA · EURONEXT:ABLD | US$41.26M | US$42.31M | 38.1× | 5.5× | 42.8× | 5.3× | 14.2% | 0.3× | n/a |
| hVIVO plc · LSE:HVO | US$40.99M | US$42.21M | n/a | 0.7× | 7.5× | 1.0× | −12.8% | 0.4× | n/a |
| Harvard Bioscience, Inc. · NASDAQ:HBIO | US$39.60M | US$71.90M | n/a | 0.8× | 28.4× | 7.8× | −13.2% | 7.3× | 1.34 |
| CytoGen, Inc. · KRX:217330 | US$38.59M | US$31.67M | n/a | 1.6× | n/a | 1.6× | −38.5% | 0.4× | n/a |
| IXICO PLC · LSE:IXI | US$37.25M | US$35.79M | n/a | 4.2× | n/a | 2.7× | −25.3% | 0.1× | n/a |
| Mabion SA · GPW:MAB | US$35.40M | US$41.96M | n/a | 9.7× | n/a | 6.0× | −321.4% | 1.3× | n/a |
| Trajan Group Holdings Ltd · ASX:TRJ | US$34.92M | US$64.94M | n/a | 0.6× | 7.6× | 0.5× | −0.4% | 0.6× | n/a |
| Novacyt SAS · EURONEXT:ALNOV | US$33.86M | US$35.58M | n/a | 0.8× | n/a | 1.4× | −102.4% | 0.6× | n/a |
| Rapid Micro Biosystems, Inc. · NASDAQ:RPID | US$33.56M | US$46.06M | n/a | 1.3× | n/a | 3.8× | −138.2% | 2.2× | 1.41 |
| Median of the others | US$37.92M | US$42.08M | 38.1× | 1.0× | 18.0× | 2.1× | −19.2% | 0.5× | 1.38 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.1B | 25.4B | 13.8B | 471.3B | 321.8B | 45.7B | 9.15B | 9.66B | 8.51B | 0 |
| Cost of revenue | 27.9B | 24.3B | 50.8B | 215.4B | 111.4B | 14.9B | 5.21B | 5.98B | 4.89B | 0 |
| Gross profit | 2.23B | 1.13B | -36.9B | 255.9B | 210.4B | 30.9B | 3.94B | 3.68B | 3.62B | 0 |
| Research and development | 406.9M | 1.53B | 4.13B | 5.23B | 3.37B | 1.46B | ||||
| Selling, general and administrative | 4.30B | 8.43B | 10.4B | 35.5B | 13.2B | 3.80B | 3.26B | 3.06B | 2.56B | 46.7M |
| Operating income | -14.0B | -45.9B | -60.6B | 209.3B | 193.6B | 25.5B | -875.3M | -1.03B | -137.2M | -46.7M |
| Depreciation and amortization | 3.00B | 1.89B | 4.55B | 4.81B | 1.96B | 758.8M | 595.1M | 530.7M | 387.4M | |
| EBITDA | -11.0B | -44.0B | -56.0B | 214.1B | 195.6B | 26.3B | -280.2M | -501.2M | 250.2M | |
| Interest expense | 2.23B | 1.03B | 67.9M | 94.0M | 117.6M | 265.8M | 0 | 0 | 0 | 0 |
| Income before tax | -21.3B | -37.6B | -62.2B | 237.6B | 196.7B | 21.1B | -1.23B | -852.8M | -3.08B | 113.9M |
| Income tax | 24.6M | 3.28B | -955.1M | |||||||
| Net income | -15.6B | -30.4B | -55.4B | 182.6B | 151.2B | 21.1B | -1.23B | -852.8M | -4.72B | 110.6M |
| Earnings per share, basic | -690.25 | -269.03 | -435.68 | 1,425.37 | 1,105.49 | 616.58 | -43.57 | -7.61 | -44.79 | 19.57 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.7B | 1.25M | 12.3B | 942.2K | 1.10M | 14.3B | 3.79B | |||
| Short-term investments | 190.1B | 185.2B | 230.7B | 299.1B | 18.6B | 8.69B | 17.8B | 19.2B | 14.0B | 12.1B |
| Receivables | 2.90B | 4.48B | 1.49B | 4.79B | 29.7B | 6.28B | 1.10B | 2.33B | 2.17B | 12.8M |
| Inventory | 5.22B | 8.85B | 8.16B | 42.5B | 51.9B | 10.5B | 2.93B | 2.70B | 2.60B | |
| Current assets | 220.1B | 212.6B | 277.8B | 372.8B | 294.6B | 42.6B | 25.8B | 26.0B | 20.5B | 12.1B |
| Property, plant and equipment | 69.7B | 57.6B | 78.9B | 44.1B | 24.7B | 10.4B | 8.02B | 7.59B | ||
| Goodwill | 1.27B | 3.23B | ||||||||
| Total assets | 327.0B | 331.9B | 347.3B | 467.5B | 340.7B | 68.3B | 36.5B | 34.3B | 28.3B | 12.1B |
| Accounts payable | 267.5M | 234.7M | 456.3M | 6.22B | 34.3B | 2.46B | 655.7M | |||
| Current liabilities | 90.8B | 81.2B | 59.8B | 118.1B | 135.5B | 9.67B | 15.5B | 5.16B | 5.90B | |
| Long-term debt | 338.3M | 318.0M | 44.5M | 0 | 8.61B | 4.84B | 7.87B | 5.81B | 1.23B | |
| Total debt | 11.9B | 7.30B | ||||||||
| Total liabilities | 91.7B | 102.7B | 60.0B | 120.8B | 138.7B | 19.5B | 21.2B | 18.2B | 12.7B | 1.26B |
| Shareholders' equity | 215.1B | 229.3B | 287.3B | 346.7B | 202.0B | 48.8B | 15.2B | 16.1B | 15.6B | 10.9B |
| Shares outstanding | 22.6M | 113.2M | 127.2M | 128.1M | 136.8M | 34.2M | 28.1M | 112.0M | 105.3M | 5.65M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 10.1B | 30.4B | -55.5B | 202.6B | 205.0B | 14.3B | 779.6M | -747.1M | -2.97B | 151.1M |
| Capital spending | -443.1M | -1.38B | -23.3B | -44.6B | -18.1B | -15.1B | -2.99B | -990.3M | -1.25B | 0 |
| Free cash flow | 9.70B | 23.6B | -78.8B | 158.0B | 186.9B | -786.8M | -2.21B | -1.74B | -4.21B | 151.1M |
| Cash from investing | -4.52B | 54.1B | -322.7B | -31.4B | -5.95B | -1.27B | -6.12B | -9.81B | -151.0M | |
| Cash from financing | -28.9B | -5.93B | -37.4B | -12.1B | 2.68B | 2.68B | 7.00B | 13.7B | 2.30B | |
| Dividends paid | 0 | -6.84B | ||||||||
| Share buybacks | -27.0B | -5.14B | -29.9B | 388.9M | 11.3B | |||||
| Change in cash | 6.25B | -2.84B | -7.30B | -157.0B | 162.3B | 10.5B | 2.15B | 128.5M | 910.1M | 130.0K |
Cap table
Built by 6ix from HUMASIS Co., Ltd.’s releases
- Common shares
- 22,618,920
- Fully diluted
- 22,618,920
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 22,618,920 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 22,618,920 |
Log in to ask 6ix AI your own questions about HUMASIS Co., Ltd.